PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,700,268 | -9.6% | 1,597,478 | -5.5% | 0.01% | 0.0% |
| Q2 2023 | $30,639,234 | -5.2% | 1,690,907 | +39.2% | 0.01% | -14.3% |
| Q1 2023 | $32,311,765 | +57.4% | 1,214,728 | +14.4% | 0.01% | +75.0% |
| Q4 2022 | $20,526,933 | +90.7% | 1,061,921 | +106.1% | 0.00% | +100.0% |
| Q3 2022 | $10,765,000 | -4.3% | 515,288 | -63.3% | 0.00% | -33.3% |
| Q2 2022 | $11,244,000 | +16.4% | 1,403,627 | +1.9% | 0.00% | +50.0% |
| Q1 2022 | $9,657,000 | -46.5% | 1,377,508 | +3.0% | 0.00% | -50.0% |
| Q4 2021 | $18,051,000 | -20.4% | 1,337,126 | -0.4% | 0.00% | -20.0% |
| Q3 2021 | $22,673,000 | -35.0% | 1,343,166 | +12.1% | 0.01% | -37.5% |
| Q2 2021 | $34,898,000 | -27.4% | 1,198,405 | -1.9% | 0.01% | -33.3% |
| Q1 2021 | $48,068,000 | +71.7% | 1,222,180 | -0.8% | 0.01% | +71.4% |
| Q4 2020 | $27,997,000 | +0.5% | 1,232,258 | +0.2% | 0.01% | -12.5% |
| Q3 2020 | $27,847,000 | -30.4% | 1,229,433 | -0.3% | 0.01% | -42.9% |
| Q2 2020 | $40,016,000 | – | 1,232,780 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |